Your partner in Europe
  • Print page
  • Bookmark Page

Contact us

Pharmacovigilance

Side effects notifications following the use of Recordati/Innova Pharma medicinal products

 

Join us:

Email: svil@recordati.it

 

Investor Relations:

Email: inver@recordati.it

 

Communicatons:

Email: comimagen@recordati.it

 

Media Relations:

Email: norismorano@studionorismorano.com

 

Pharmaceutical chemicals:

Email: pharmachemicals@recordati.it

 

Last updated on:
17/11/14
10:41:29 CET
Delivered by Investis (opens in a new window)